PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2015

HINT1 protein: a new therapeutic target to enhance opioid antinociception and block mechanical allodynia.

Mouse / Other

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 25445489 ↗2015Reported benefit

HINT1 protein: a new therapeutic target to enhance opioid antinociception and block mechanical allodynia.

MouseOtherMaleIntracerebroventricularAfter establishment of chronic constriction injury

Model: Chronic constriction injury of the sciatic nerve producing neuropathic mechanical allodynia

A single intracerebroventricular dose of TpGc attenuated NMDA receptor function and alleviated mechanical allodynia for several days, and TpGc enhanced morphine antinociception while preventing tolerance.

Extraction: extract · Supplied extraction confidence: 0.6. Machine-extracted fields require source verification.